73 related articles for article (PubMed ID: 36514506)
21. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
[TBL] [Abstract][Full Text] [Related]
22. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma.
Manna D; Sarkar D
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429062
[TBL] [Abstract][Full Text] [Related]
23. DNA Methylation Regulates Alternative Polyadenylation via CTCF and the Cohesin Complex.
Nanavaty V; Abrash EW; Hong C; Park S; Fink EE; Li Z; Sweet TJ; Bhasin JM; Singuri S; Lee BH; Hwang TH; Ting AH
Mol Cell; 2020 May; 78(4):752-764.e6. PubMed ID: 32333838
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of Hepatocellular Carcinoma.
McGlynn KA; Petrick JL; El-Serag HB
Hepatology; 2021 Jan; 73 Suppl 1(Suppl 1):4-13. PubMed ID: 32319693
[TBL] [Abstract][Full Text] [Related]
25. IFITM3 upregulates c-myc expression to promote hepatocellular carcinoma proliferation via the ERK1/2 signalling pathway.
Min J; Hu J; Luo C; Zhu J; Zhao J; Zhu Z; Wu L; Yuan R
Biosci Trends; 2020 Jan; 13(6):523-529. PubMed ID: 31852866
[TBL] [Abstract][Full Text] [Related]
26. TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription.
Yu JM; Sun W; Wang ZH; Liang X; Hua F; Li K; Lv XX; Zhang XW; Liu YY; Yu JJ; Liu SS; Shang S; Wang F; Yang ZN; Zhao CX; Hou XY; Li PP; Huang B; Cui B; Hu ZW
Nat Commun; 2019 Dec; 10(1):5720. PubMed ID: 31844113
[TBL] [Abstract][Full Text] [Related]
27. Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.
Jee BA; Choi JH; Rhee H; Yoon S; Kwon SM; Nahm JH; Yoo JE; Jeon Y; Choi GH; Woo HG; Park YN
Cancer Res; 2019 Nov; 79(21):5500-5512. PubMed ID: 31506333
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
Perez S; Kaspi A; Domovitz T; Davidovich A; Lavi-Itzkovitz A; Meirson T; Alison Holmes J; Dai CY; Huang CF; Chung RT; Nimer A; El-Osta A; Yaari G; Stemmer SM; Yu ML; Haviv I; Gal-Tanamy M
PLoS Genet; 2019 Jun; 15(6):e1008181. PubMed ID: 31216276
[TBL] [Abstract][Full Text] [Related]
29. Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis.
Hisada Y; Mackman N
Semin Thromb Hemost; 2019 Jun; 45(4):385-395. PubMed ID: 31096306
[TBL] [Abstract][Full Text] [Related]
30. HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
Hamdane N; Jühling F; Crouchet E; El Saghire H; Thumann C; Oudot MA; Bandiera S; Saviano A; Ponsolles C; Roca Suarez AA; Li S; Fujiwara N; Ono A; Davidson I; Bardeesy N; Schmidl C; Bock C; Schuster C; Lupberger J; Habersetzer F; Doffoël M; Piardi T; Sommacale D; Imamura M; Uchida T; Ohdan H; Aikata H; Chayama K; Boldanova T; Pessaux P; Fuchs BC; Hoshida Y; Zeisel MB; Duong FHT; Baumert TF
Gastroenterology; 2019 Jun; 156(8):2313-2329.e7. PubMed ID: 30836093
[TBL] [Abstract][Full Text] [Related]
31. Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets.
Yang YM; Kim SY; Seki E
Semin Liver Dis; 2019 Feb; 39(1):26-42. PubMed ID: 30809789
[TBL] [Abstract][Full Text] [Related]
32. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
33. fastp: an ultra-fast all-in-one FASTQ preprocessor.
Chen S; Zhou Y; Chen Y; Gu J
Bioinformatics; 2018 Sep; 34(17):i884-i890. PubMed ID: 30423086
[TBL] [Abstract][Full Text] [Related]
34. The Human Transcription Factors.
Lambert SA; Jolma A; Campitelli LF; Das PK; Yin Y; Albu M; Chen X; Taipale J; Hughes TR; Weirauch MT
Cell; 2018 Oct; 175(2):598-599. PubMed ID: 30290144
[No Abstract] [Full Text] [Related]
35. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.
Lee YS; Lee DH; Jeong SY; Park SH; Oh SC; Park YS; Yu J; Choudry HA; Bartlett DL; Lee YJ
J Cell Biochem; 2019 Jan; 120(1):928-939. PubMed ID: 30160785
[TBL] [Abstract][Full Text] [Related]
36. Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals.
Debes JD; van Tilborg M; Groothuismink ZMA; Hansen BE; Schulze Zur Wiesch J; von Felden J; de Knegt RJ; Boonstra A
Gastroenterology; 2018 Feb; 154(3):515-517.e3. PubMed ID: 29102620
[TBL] [Abstract][Full Text] [Related]
37. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions.
Han H; Cho JW; Lee S; Yun A; Kim H; Bae D; Yang S; Kim CY; Lee M; Kim E; Lee S; Kang B; Jeong D; Kim Y; Jeon HN; Jung H; Nam S; Chung M; Kim JH; Lee I
Nucleic Acids Res; 2018 Jan; 46(D1):D380-D386. PubMed ID: 29087512
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.
;
Cell; 2017 Jun; 169(7):1327-1341.e23. PubMed ID: 28622513
[TBL] [Abstract][Full Text] [Related]
39. How to stomach an epigenetic insult: the gastric cancer epigenome.
Padmanabhan N; Ushijima T; Tan P
Nat Rev Gastroenterol Hepatol; 2017 Aug; 14(8):467-478. PubMed ID: 28513632
[TBL] [Abstract][Full Text] [Related]
40. Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.
Shen Y; Chen TJ; Lacorazza HD
Exp Hematol; 2017 Sep; 53():16-25. PubMed ID: 28479419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
